Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlbion Venture Regulatory News (AAVC)

Share Price Information for Albion Venture (AAVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.20
Bid: 42.20
Ask: 44.20
Change: 0.00 (0.00%)
Spread: 2.00 (4.739%)
Open: 43.20
High: 43.20
Low: 43.20
Prev. Close: 43.20
AAVC Live PriceLast checked at -
Albion VCT is an Investment Trust

To manage risk normally associated with investments in smaller, unquoted growth businesses across a variety of sectors including higher risk technology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Albion Venture Capital Trust PLC: Interim Management Statement

7 Sep 2021 11:32

Albion Venture Capital Trust PLC: Interim Management Statement

ALBION VENTURE CAPITAL TRUST PLC

LEI Code: 213800JKELS32V2OK421 Interim Management Statement

 

Introduction I am pleased to present Albion Venture Capital Trust PLC (the “Company”)’s interim management statement for the period from 1 April 2021 to 30 June 2021. 

Performance and dividends

The Company's unaudited net asset value (NAV) as at 30 June 2021 was £73.4 million or 73.81 pence per share (excluding treasury shares), an increase of 0.68 pence per share (0.9 per cent.) since 31 March 2021. 

After accounting for the first dividend for the year ending 31 March 2022 of 1.83 pence per share and the special dividend of 15.00 pence per share paid on 30 July 2021 to shareholders on the register on 9 July 2021, the NAV is 56.98 pence per share. 

Portfolio The following investments have been made during the period from 1 April 2021 to 30 June 2021.

New investments£000’sActivity
Gravitee TopCo Limited (T/A gravitee.io)813API management platform.
NuvoAir AB741Digital therapeutics and decentralised clinical trials for respiratory conditions.
Brytlyt Limited577A GPU database software provider.
Accelex Technology Limited (T/A Accelex)324Data extraction and analytics technology for private capital markets.
Total new investments2,455 

Further investments£000’sActivity
uMotif Limited592A patient engagement and data capture platform for use in real world and observational research.

 

Top ten holdings (as at 30 June 2021)

InvestmentCarrying value £000’s% of net asset valueActivity
Chonais River Hydro Limited4,2555.8%Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands.
Radnor House School (TopCo) Limited2,1903.0%Independent school for children aged 2-18.
Gharagain River Hydro Limited1,7802.4%Owner and operator of a 1 MW hydro-power scheme in the Scottish Highlands.
Cantab Research Limited (T/A Speechmatics)1,7092.3%Provider of low footprint automated speech recognition which can be deployed in the cloud, on premise or on device across 29 languages.
The Evewell Group Limited1,6722.3%Operator and developer of women’s health centres focusing on fertility.
Phrasee Limited1,4001.9%AI platform that generates optimised marketing campaigns.
Elliptic Enterprises Limited1,2671.7%Provider of Anti Money Laundering services to digital asset institutions.
Threadneedle Software Holdings Limited (T/A Solidatus)1,2621.7%Provider of data lineage software to enterprise customers in regulated sectors.
The Street by Street Solar Programme Limited1,1821.6%Owner and operator of photovoltaic systems on domestic properties in the UK.
uMotif Limited1,1131.5%A patient engagement and data capture platform for use in real world and observational research.

 

A full breakdown of the Company’s portfolio can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AAVC

Share buy-backs

During the period from 1 April 2021 to 30 June 2021, the Company did not buy back any shares. 

It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders. 

It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit. 

Board composition and succession planning

The Board recognises the importance of succession planning, including the need to ensure Board continuity. As part of that planning, it is the intention of John Kerr to retire as a Director at the AGM in September 2022. The Nomination Committee will commence a recruitment process to identify candidates and announcements of a new Director appointment will be made in due course.

Shareholder seminar

The Board is pleased to report that the current intention of the Manager, Albion Capital, is to host a physical rather than virtual shareholder seminar this year on 12 November 2021, in central London with the venue to be confirmed. This will be dependent on government guidelines and any changes thereof, and we will keep shareholders informed as the date approaches. The Board and Manager are keen to interact with shareholders and look forward to sharing with you further portfolio updates, as well as answering any questions. 

More details will shortly be available on the Albion Capital website: www.albion.capital

Material events and transactions after the period end 

After the period end, the Company had the following material investment transactions: 

Investment of £409,000 in an existing portfolio company, The Evewell Group Limited, an operator and developer of women’s health centres focusing on fertility; andInvestment of £54,000 in an existing portfolio company, Imandra Inc., a provider of automated software testing and an enhanced learning experience for artificial neural networks.

Further information

The Company continues to offer a dividend reinvestment scheme to existing shareholders. Details of this Scheme can be found at www.albion.capital/funds/AAVC.

Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AAVC

Richard Glover, Chairman

7 September 2021 

For further information please contact: 

Vikash Hansrani

Operations Partner

Albion Capital Group LLP

Telephone: 020 7601 1850

 

Date   Source Headline
16th Mar 200910:00 amRNSFSA viewing facility
27th Feb 20092:59 pmRNSTotal Voting Rights
10th Feb 20093:27 pmRNSInterim Management Statement
30th Jan 20094:48 pmRNSTotal Voting Rights
23rd Jan 200911:38 amRNSChange of Investment Manager and Proposed Change o
9th Jan 20095:11 pmRNSDirector/PDMR Shareholding
9th Jan 200911:50 amRNSIssue of Equity
31st Dec 200810:45 amRNSTotal Voting Rights
10th Dec 20083:41 pmRNSTransaction in Own Shares
4th Dec 20085:09 pmRNSDoc re. Half-yearly Financial Report
2nd Dec 20085:03 pmRNSTransaction in Own Shares
28th Nov 200812:38 pmRNSTotal Voting Rights
26th Nov 20084:32 pmRNSInterim Results
31st Oct 20084:33 pmRNSTotal Voting Rights
30th Sep 20085:21 pmRNSTotal voting rights and transaction in own shares
30th Sep 20085:13 pmRNSTotal voting rights and transaction in own shares
11th Sep 20085:30 pmRNSTransaction in Own Shares
29th Aug 20083:29 pmRNSTotal Voting Rights
18th Aug 200812:23 pmRNSInterim Management Statement
15th Aug 20085:50 pmRNSDirector/PDMR Shareholding
15th Aug 200811:36 amRNSIssue of Equity
5th Aug 20081:44 pmRNSTransaction in Own Shares
31st Jul 20085:13 pmRNSTotal Voting Rights
21st Jul 20083:16 pmRNSFSA document viewing facility
15th Jul 200810:00 amRNSAnnual Information Update
10th Jul 20084:54 pmRNSFinal Results
30th Jun 20086:00 pmRNSTotal Voting Rights
30th May 20084:30 pmRNSTotal Voting Rights
30th Apr 20085:07 pmRNSTotal Voting Rights
31st Mar 20084:56 pmRNSTotal Voting Rights
29th Feb 20085:03 pmRNSTotal Voting Rights
5th Feb 20083:37 pmRNSDirector/PDMR Shareholding
4th Feb 20084:32 pmRNSInterim Management Statement
31st Jan 20084:37 pmRNSTotal Voting Rights
29th Jan 200810:25 amRNSDirector/PDMR Shareholding
2nd Jan 20085:10 pmRNSTotal Voting Rights
2nd Jan 20085:08 pmRNSDirectorate Change
17th Dec 20075:35 pmRNSTransaction in Own Shares
30th Nov 20074:39 pmRNSTotal Voting Rights
30th Nov 20074:37 pmRNSDoc re. FSA Viewing Facility
27th Nov 20075:58 pmRNSInterim Results
31st Oct 20074:11 pmRNSTotal Voting Rights
3rd Oct 200710:03 amRNSDirectorate Change
1st Oct 200711:52 amRNSTotal Voting Rights
3rd Sep 20075:30 pmRNSTotal Voting Rights
16th Aug 20074:12 pmRNSInterim Management Statement
6th Aug 20072:05 pmRNSResult of AGM
1st Aug 20073:14 pmRNSTotal Voting Rights
6th Jul 20073:10 pmRNSAnnual Information Update
6th Jul 20073:03 pmRNSFSA document viewing facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.